|
1
|
Hockel M and Vaupel P: Tumor hypoxia:
definitions and current clinical, biologic, and molecular aspects.
J Natl Cancer Inst. 93:266–276. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Semenza GL: Life with oxygen. Science.
318:62–64. 2007. View Article : Google Scholar
|
|
3
|
Brahimi-Horn MC and Pouyssegur J:
Harnessing the hypoxia-inducible factor in cancer and ischemic
disease. Biochem Pharmacol. 73:450–457. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bachtiary B, Schindl M, Potter R, et al:
Overexpression of hypoxia-inducible factor 1alpha indicates
diminished response to radiotherapy and unfavorable prognosis in
patients receiving radical radiotherapy for cervical cancer. Clin
Cancer Res. 9:2234–2240. 2003.
|
|
5
|
Birner P, Schindl M, Obermair A, Plank C,
Breitenecker G and Oberhuber G: Overexpression of hypoxia-inducible
factor 1alpha is a marker for an unfavorable prognosis in
early-stage invasive cervical cancer. Cancer Res. 60:4693–4696.
2000.PubMed/NCBI
|
|
6
|
Giordano FJ and Johnson RS: Angiogenesis:
the role of the microenvironment in flipping the switch. Curr Opin
Genet Dev. 11:35–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang LE, Arany Z, Livingston DM and Bunn
HF: Activation of hypoxia-inducible transcription factor depends
primarily upon redox-sensitive stabilization of its alpha subunit.
J Biol Chem. 271:32253–32259. 1996. View Article : Google Scholar
|
|
8
|
Maxwell PH, Wiesener MS, Chang GW, et al:
The tumour suppressor protein VHL targets hypoxia-inducible factors
for oxygen-dependent proteolysis. Nature. 399:271–275. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cockman ME, Masson N, Mole DR, et al:
Hypoxia inducible factor-alpha binding and ubiquitylation by the
von Hippel-Lindau tumor suppressor protein. J Biol Chem.
275:25733–25741. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang BH, Rue E, Wang GL, Roe R and
Semenza GL: Dimerization, DNA binding, and transactivation
properties of hypoxia-inducible factor 1. J Biol Chem.
271:17771–17778. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maxwell PH, Dachs GU, Gleadle JM, et al:
Hypoxia-inducible factor-1 modulates gene expression in solid
tumors and influences both angiogenesis and tumor growth. Proc Natl
Acad Sci USA. 94:8104–8109. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hopfl G, Wenger RH, Ziegler U, et al:
Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by
wild-type cells is independent of vascular endothelial growth
factor. Cancer Res. 62:2962–2970. 2002.PubMed/NCBI
|
|
13
|
Kung AL, Wang S, Klco JM, Kaelin WG and
Livingston DM: Suppression of tumor growth through disruption of
hypoxia-inducible transcription. Nat Med. 6:1335–1340. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ryan HE, Lo J and Johnson RS: HIF-1 alpha
is required for solid tumor formation and embryonic
vascularization. EMBO J. 17:3005–3015. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ryan HE, Poloni M, McNulty W, et al:
Hypoxia-inducible factor-1alpha is a positive factor in solid tumor
growth. Cancer Res. 60:4010–4015. 2000.PubMed/NCBI
|
|
16
|
Chen J, Zhao S, Nakada K, et al:
Dominant-negative hypoxia-inducible factor-1 alpha reduces
tumorigenicity of pancreatic cancer cells through the suppression
of glucose metabolism. Am J Pathol. 162:1283–1291. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Erler JT, Bennewith KL, Nicolau M, et al:
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature.
440:1222–1226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liao D, Corle C, Seagroves TN and Johnson
RS: Hypoxia-inducible factor-1alpha is a key regulator of
metastasis in a transgenic model of cancer initiation and
progression. Cancer Res. 67:563–572. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Giatromanolaki A, Koukourakis MI, Sivridis
E, et al: Relation of hypoxia inducible factor 1 alpha and 2 alpha
in operable non-small cell lung cancer to angiogenic/molecular
profile of tumours and survival. Br J Cancer. 85:881–890. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Talks KL, Turley H, Gatter KC, et al: The
expression and distribution of the hypoxia-inducible factors
HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and
tumor-associated macrophages. Am J Pathol. 157:411–421. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blancher C, Moore JW, Talks KL, Houlbrook
S and Harris AL: Relationship of hypoxia-inducible factor
(HIF)-1alpha and HIF-2alpha expression to vascular endothelial
growth factor induction and hypoxia survival in human breast cancer
cell lines. Cancer Res. 60:7106–7113. 2000.
|
|
22
|
Koukourakis MI, Giatromanolaki A, Sivridis
E, et al: Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis,
and chemoradiotherapy outcome of squamous cell head-and-neck
cancer. Int J Radiat Oncol Biol Phys. 53:1192–1202. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koukourakis MI, Giatromanolaki A,
Skarlatos J, et al: Hypoxia inducible factor (HIF-1α and HIF-2α)
expression in early esophageal cancer and response to photodynamic
therapy and radiotherapy. Cancer Res. 61:1830–1832. 2001.
|
|
24
|
Sermeus A, Cosse JP, Crespin M, et al:
Hypoxia induces protection against etoposide-induced apoptosis:
molecular profiling of changes in gene expression and transcription
factor activity. Mol Cancer. 7:272008. View Article : Google Scholar
|
|
25
|
Zhong H, De Marzo AM, Laughner E, et al:
Overexpression of hypoxia-inducible factor 1alpha in common human
cancers and their metastases. Cancer Res. 59:5830–5835.
1999.PubMed/NCBI
|
|
26
|
Peng XH, Karna P, Cao Z, Jiang BH, Zhou M
and Yang L: Cross-talk between epidermal growth factor receptor and
hypoxia-inducible factor-1alpha signal pathways increases
resistance to apoptosis by up-regulating survivin gene expression.
J Biol Chem. 281:25903–25914. 2006. View Article : Google Scholar
|
|
27
|
Shibaji T, Nagao M, Ikeda N, et al:
Prognostic significance of HIF-1 alpha overexpression in human
pancreatic cancer. Anticancer Res. 23:4721–4727. 2003.PubMed/NCBI
|
|
28
|
Bos R, van der Groep P, Greijer AE, et al:
Levels of hypoxia-inducible factor-1alpha independently predict
prognosis in patients with lymph node negative breast carcinoma.
Cancer. 97:1573–1581. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ramanathan M, Luo W, Csoka B, et al:
Differential regulation of HIF-1alpha isoforms in murine
macrophages by TLR4 and adenosine A(2A) receptor agonists. J Leukoc
Biol. 86:681–689. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zheng X, Ruas JL, Cao R, et al:
Cell-type-specific regulation of degradation of hypoxia-inducible
factor 1 alpha: role of subcellular compartmentalization. Mol Cell
Biol. 26:4628–4641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leek RD, Stratford I and Harris AL: The
role of hypoxia-inducible factor-1 in three-dimensional tumor
growth, apoptosis, and regulation by the insulin-signaling pathway.
Cancer Res. 65:4147–4152. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang G, Reisdorph R, Clark RE Jr,
Miskimins R, Lindahl R and Miskimins WK: Cyclin dependent kinase
inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent
pathway. J Cell Biochem. 90:548–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Goda N, Ryan HE, Khadivi B, McNulty W,
Rickert RC and Johnson RS: Hypoxia-inducible factor 1alpha is
essential for cell cycle arrest during hypoxia. Mol Cell Biol.
23:359–369. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schipani E, Ryan HE, Didrickson S,
Kobayashi T, Knight M and Johnson RS: Hypoxia in cartilage:
HIF-1alpha is essential for chondrocyte growth arrest and survival.
Genes Dev. 15:2865–2876. 2001.PubMed/NCBI
|
